Maciej Grzegorz Robaczyk

Clinical Associate Professor and Senior Physician at Aalborg University Hospital within the Faculty of Health Sciences, Department of Diabetes and Hormonal Diseases. Primary institutional affiliation with Aalborg University in Denmark, focusing on endocrine disorders through clinical practice and research.

Research interests center on neuroendocrine tumors and calcium metabolism disorders, particularly pheochromocytoma, paraganglioma, and primary hyperparathyroidism. Expertise spans retrospective cohort studies, systematic reviews, and clinical trials investigating disease incidence, pregnancy complications, surgical outcomes, and novel pharmacotherapies. Key contributions include population-based epidemiological analyses and multicenter collaborative studies.

Publication trends reveal consistent high-impact research in premier endocrinology journals (The Lancet Diabetes and Endocrinology, Journal of Clinical Endocrinology and Metabolism), with emphasis on translational studies bridging clinical observations and therapeutic innovations. Recent work demonstrates leadership in international collaborations examining rare endocrine conditions.

PhD supervision activities are documented but specific student names are not publicly listed. Research is disseminated through nine publications between 2017-2021 including journal articles, conference abstracts, and systematic reviews.

Active in clinical research networks with collaborations evidenced through co-authorship on multicenter studies, particularly within the International Pheochromocytoma and Pregnancy Study Group. Work integrates hospital-based clinical data with academic research frameworks to address critical gaps in endocrine oncology and metabolic bone disease management.